Ra Pharmaceuticals Inc buy stratec
Start price
20.07.18
/
50%
€9.86
Target price
03.04.20
€51.65
Performance (%)
344.27%
End price
03.04.20
-
Summary
This prediction ended on 03.04.20 with a price of -. The BUY prediction by stratec for Ra Pharmaceuticals Inc saw massive gains of 344.27%. stratec has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Ra Pharmaceuticals Inc | 3.256% | 3.256% | - | - |
| iShares Core DAX® | -0.168% | 4.802% | 17.488% | 17.061% |
| iShares Nasdaq 100 | 2.946% | 3.520% | 23.619% | 36.065% |
| iShares Nikkei 225® | 1.319% | 6.746% | 12.949% | 0.580% |
| iShares S&P 500 | 2.044% | 3.551% | 23.055% | 39.407% |
Comments by stratec for this prediction
In the thread Ra Pharmaceuticals Inc diskutieren
stratec stimmt dem Sentiment von 'Buy' zu
- Ra Pharmaceuticals (NASDAQ:RARX) initiated with Outperform rating and $20 (82% upside) price target at BMO.
Kursziel geändert auf 51,648